
StudyFinder
A longitudinal study of imaging biomarkers in amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS)

Status: Recruiting
The purpose of the study is to test new biomarkers of amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS) using MRI scans at 3 tesla (3T). Identifying biomarkers of a disease can lead to a better understanding of the disease as well as improved treatments.
Sex: Male or Female
Age Group: 18 years and over
Inclusion Criteria:
• 21 to 75 years old
• diagnosis of possible, laboratory-supported probable, probable, or definite ALS or PLS
Exclusion Criteria:
• other neurodegenerative diseases (Parkinson disease, Alzheimer's disease, etc).
• inability to undergo MRI scanning
• needs assistance to walk or climb stairs
Conditions:
Brain & Nervous System, Rare Diseases
Keywords:
ALS, Amyotrophic Lateral Sclerosis, Primary Lateral Sclerosis
Study Contact: Valerie Ferment - ferm0016@umn.edu
Principal Investigator: David Walk
IRB Number: 1306M35941
See this study on ClinicalTrials.gov